143 related articles for article (PubMed ID: 37719966)
1. Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization.
Zhong BY; Jiang JQ; Sun JH; Huang JT; Wang WD; Wang Q; Ding WB; Zhu XL; Ni CF
J Clin Transl Hepatol; 2023 Nov; 11(6):1321-1328. PubMed ID: 37719966
[TBL] [Abstract][Full Text] [Related]
2. Multicentric Assessment of the Hong Kong Liver Cancer Staging System in Chinese Patients Following Transarterial Chemoembolization.
Zhong BY; Ni CF; Yin GW; Chen L; Zhu HD; Guo JH; He SC; Deng G; Zhang Q; Li PC; Yu H; Teng GJ
Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1867-1876. PubMed ID: 30073478
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy.
Sohn JH; Duran R; Zhao Y; Fleckenstein F; Chapiro J; Sahu S; Schernthaner RE; Qian T; Lee H; Zhao L; Hamilton J; Frangakis C; Lin M; Salem R; Geschwind JF
Clin Gastroenterol Hepatol; 2017 May; 15(5):746-755.e4. PubMed ID: 27847278
[TBL] [Abstract][Full Text] [Related]
4. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
Liao R; Wei XF; Che P; Yin KL; Liu L
Front Oncol; 2021; 11():755920. PubMed ID: 35127471
[TBL] [Abstract][Full Text] [Related]
5. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
6. The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
Op den Winkel M; Nagel D; Op den Winkel P; Paprottka PM; Schmidt L; Bourhis H; Trojan J; Goeller M; Reiter FP; Stecher SS; De Toni EN; Gerbes AL; Kolligs FT
Digestion; 2019; 100(1):15-26. PubMed ID: 30282074
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.
Op den Winkel M; Nagel D; Op den Winkel P; Trojan J; Paprottka PM; Steib CJ; Schmidt L; Göller M; Stieber P; Göhring P; Herbst A; Rentsch M; De Toni EN; Göke B; Gerbes AL; Kolligs FT
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):44-53. PubMed ID: 29076939
[TBL] [Abstract][Full Text] [Related]
9. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
10. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
11. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
Shuanggang C; Shen L; Qiu Z; Qi H; Cao F; Xie L; Fan W
J Cancer Res Ther; 2020; 16(2):250-257. PubMed ID: 32474509
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
14. Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Campani C; Vitale A; Dragoni G; Arena U; Laffi G; Cillo U; Giannini EG; Tovoli F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Sacco R; Cabibbo G; Mega A; Guarino M; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Biasini E; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Brunetto MR; Farinati F; Trevisani F; Marra F
Liver Cancer; 2021 Apr; 10(2):126-136. PubMed ID: 33977089
[TBL] [Abstract][Full Text] [Related]
15. Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
Yang B; Zheng B; Yang M; Zeng Z; Yang F; Pu J; Li C; Liao Z
Hepatol Int; 2018 Sep; 12(5):417-428. PubMed ID: 30073454
[TBL] [Abstract][Full Text] [Related]
16. Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Biolato M; Gallusi G; Iavarone M; Cabibbo G; Racco S; De Santis A; Corte CD; Maida M; Attili AF; Sangiovanni A; Cammà C; La Torre G; Gasbarrini A; Grieco A
Ann Hepatol; 2018; 17(1):110-118. PubMed ID: 29311396
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization
Yang B; Yuan M; Yang T; Liao Z; Wu H
Oncol Res; 2022; 30(1):23-33. PubMed ID: 37304009
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma.
Ishikawa K; Chiba T; Ooka Y; Suzuki E; Ogasawara S; Maeda T; Yokoyama M; Inoue M; Wakamatsu T; Kusakabe Y; Saito T; Tawada A; Arai M; Kanda T; Maruyama H; Imazeki F; Kato N
Oncotarget; 2018 Apr; 9(30):21560-21568. PubMed ID: 29765560
[TBL] [Abstract][Full Text] [Related]
19. A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.
Mei J; Li SH; Wang QX; Zhong XP; Lu LH; Kan A; Wei W; Guo RP
Cancer Med; 2020 Jan; 9(1):62-76. PubMed ID: 31701652
[TBL] [Abstract][Full Text] [Related]
20. The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization.
Arizumi T; Ueshima K; Iwanishi M; Minami T; Chishina H; Kono M; Takita M; Yada N; Hagiwara S; Minami Y; Ida H; Komeda Y; Takenaka M; Sakurai T; Watanabe T; Nishida N; Kudo M
Liver Cancer; 2017 Jun; 6(3):227-235. PubMed ID: 28626733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
